Observe Medical

Observe Medical ASA - Received Innovation Norway Loan Commitment of NOK 15 million

Oslo, 19 December 2025 - Observe Medical ASA (the "Company" or "Observe

Medical", OSE ticker "OBSRV") has received a loan commitment from Innovation

Norway for a loan of NOK 15 million to support the continued commercialisation

of the Company's UnoMeterT product portfolio, and commercial preparation for the

launch of Sippi®.

The availability of the loan is subject to execution of final loan documentation

and certain customary conditions precedent.

Further information regarding final terms and drawdown will be provided once the

loan agreement has been executed.

Jørgen Mann, CEO of Observe Medical, commented: "We consider the loan commitment

from Innovation Norway to be an important milestone for Observe Medical. During

2025, the Company completed equity financings raising gross proceeds of NOK 58.5

million, and in combination with the loan from Innovation Norway we are now able

increase the speed and momentum in the ongoing commercialisation of the

UnoMeterT portfolio including the rollout of the defined product pipeline.

Furthermore, it will allow us to take steps to implement our full corporate

strategy to be a partner for the Nordic innovative ecosystem within the Medtech

area"

This information is considered to constitute inside information pursuant to the

EU Market Abuse Regulation and is subject to disclosure requirements pursuant to

section 5-12 of the Norwegian Securities Trading Act. This announcement was

published by Johan Fagerli, CFO, on 19. December 2025 at 15:30 CET

For further information, please contact:

Jørgen Mann, CEO Observe Medical

Mobile: +45 408 67 558

Johan Fagerli, CFO Observe Medical

Mobile: +47 958 12 765

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells

innovative medtech products for the global market. The Company is committed to

improving patient welfare and patient outcomes, improving clinical data accuracy

and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and

commercialization of its broad portfolio of medical technology products, mainly

in urine measurement and ultrasound, in combination with targeted M&A and

distribution. Observe Medical is working with a network of leading distributors

to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at www.observemedical.com.

AI Terminal